HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intervention study of Snyder's hope theory on the stigma of stroke in young and middle-aged patients: a randomised trial.

AbstractBACKGROUND:
Stigma refers to the sense of discrimination that society has towards a certain group of people, and this part of the group will also have a sense of shame due to their own negative circumstance. Young and middle-aged stroke patients need long-term effective support from their families and society, which can easily produce shame, and have a negative impact on disease treatment.
METHODS:
A total of 94 young and middle-aged stroke patients admitted to our hospital from November 2018 to November 2020 were selected and randomly allocated to 2 groups, with 47 cases in each group. The control group received routine intervention, and the observation group received SHT intervention. The stigma, hope level, compliance with functional exercise, National Institute of Health Stroke Scale (NIHSS) score and changes in activities of daily living were compared between the 2 groups before and after intervention.
RESULTS:
The total scores of social interaction, treatment, ability, and stigma of the observation group were lower than those of the control group after 1 month of intervention (P<0.05). The observation group's positive attitude towards reality and the future, taking positive actions, maintaining close relationships with others, and hope levels after 1 month of intervention were all higher than the control group (P<0.05). The functional exercise compliance of the observation group was higher than that of the control group after 1 month of intervention (P<0.05). The Barthel index score of the observation group was higher than that of the control group after 1 month of intervention, and the NIHSS score was lower than that of the control group (P<0.05).
CONCLUSIONS:
The application of SHT to young and middle-aged stroke patients can reduce stigma, improve hope level and compliance with functional exercise, improve neurological function, and enhance the ability for daily living.
TRIAL REGISTRATION:
Chinese Clinical Trial Registry ChiCTR2100045926.
AuthorsChunxia Ge, Hua Zhang, Guoyun Zhu, Aiping Cao, Jianping Zhang
JournalAnnals of palliative medicine (Ann Palliat Med) Vol. 10 Issue 5 Pg. 5721-5728 (May 2021) ISSN: 2224-5839 [Electronic] China
PMID33977743 (Publication Type: Journal Article, Randomized Controlled Trial)
Topics
  • Activities of Daily Living
  • Humans
  • Middle Aged
  • Stroke (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: